# BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation

> **NCT05813132** · NA · COMPLETED · sponsor: **Rehab Werida** · enrollment: 58 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** BEAM Protocol
- **DRUG:** CEM protocol

## Key facts

- **NCT ID:** NCT05813132
- **Lead sponsor:** Rehab Werida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-11
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05813132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05813132, "BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05813132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*